• 1
    Baldwin P, Laskey R, Coleman N. Translational approaches to improving cervical screening. Nature Rev. 2003; 3: 217226.
  • 2
    Hutchinson ML, Cassin CM, Ball HGIII. The efficacy of an automated preparation device for cervical cytology. Am J Clin Pathol. 1991; 96: 300305.
  • 3
    Agoff SN, Dean T, Nixon BK. The efficacy of reprocessing unsatisfactory cervicovaginal ThinPrep specimens with and without glacial acetic acid. Am J Clin Pathol. 2002; 118: 727732.
  • 4
    Bentz JS, Rowe LR, Gopez EV, Marshall CJ. The unsatisfactory Pap test. Missed opportunity for disease detection? Am J Clin Pathol. 2002; 117: 457463.
  • 5
    Islam S, West AM, Saboorian MH, Ashfaq R. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions. Cancer (Cancer Cytopathol). 2004; 102: 6773.
  • 6
    Rowe LR, Bentz JS. A simple method to determine the need for glacial acetic acid treatment of bloody ThinPrep Pap tests before slide processing. Diagn Cytopathol. 2004; 31: 321325.
  • 7
    Sweeney BJ, Haq Z, Happel JF, Weinstein B, Schneider D. Comparison of the effectiveness of two liquid-based Papanicolaou systems in the handling of adverse limiting factors, such as excessive blood. Cancer (Cancer Cytopathol). 2005; 21: 2731.
  • 8
    Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol. 2000; 44: 726742.
  • 9
    Castle PE, Wheeler CM, Solomon D, Schiffman M, Peyton CL, for the ALTS Group. Interlaboratory reliability of Hybrid Capture 2. Am J Clin Pathol. 2004; 122: 238245.
  • 10
    Lorincz A. Hybrid Capture™ method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep. 1996; 7: 15.
  • 11
    Sherman ME, Schiffman M, Cox JT, for Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Effects of age and human papillomaviral load on colposcopy triage: Data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2002; 94: 102107.
  • 12
    Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000; 38: 357361.
  • 13
    Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis. 2001; 183: 15541564.
  • 14
    Jastania R, Geddie WR, Chapman W, Boerner S. Characteristics of apparently false-negative Digene Hybrid Capture 2 high-risk HPV DNA testing. Am J Clin Pathol. 2006; 125: 223228.
  • 15
    Boon ME, Ouwerkerk-Noordam E, van Leeuwen AWMF, Van Haaften-Day C. Clinical and diagnostic significance of blood in cervical smears. Diagn Cytopathol. 2003; 28: 181185.
  • 16
    Gay JD, Donaldson LD, Goellner JR. False-negative results in cervical cytologic studies. Acta Cytol. 1985; 29: 10431046.
  • 17
    Henry JA, Wadehra V. Influence of smear quality on the rate of detecting significant cervical cytologic abnormalities. Acta Cytol. 1996; 40: 529535.
  • 18
    Mintzer M, Curtis P, Resnick JC, Morrell D. The effect of the quality of Papanicolaou smears on the detection of cytologic abnormalities. Cancer (Cancer Cytopathol). 1999; 87: 113117.
  • 19
    Mitchell H, Medley G, Giles G. Cervical cancers diagnosed after negative results on cervical cytology: Perspective in the 1980s. BMJ. 1990; 300: 16221626.
  • 20
    Nygard JF, Sauer T, Nygard M, Skare GB, Thoresen SO. CIN 2/3 and cervical cancer in an organized screening programme after an unsatisfactory or a normal Pap smear: A seven-year study of the Norwegian population-based screening programme. J Med Screen. 2004; 11: 7076.
  • 21
    Pairwuti S. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix. Acta Cytol. 1991; 35: 4046.
  • 22
    Ransdell JS, Davey DD, Zaleski S. Clinicopathologic correlation of the unsatisfactory Papanicolaou smear. Cancer (Cancer Cytopathol). 1997; 81: 139143.
  • 23
    Vooijs CP, van der Graaf Y, Elias AG. Cellular composition of cervical smears in relation to the day of the menstrual cycle and the methods of contraception. Acta Cytol. 1987; 31: 417426.
  • 24
    Wright TCJr, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Am J Obstet Gynecol. 2004; 103: 304309.
  • 25
    McGarahan A, Smith-McCune K. Follow-up of unsatisfactory Papanicolaou results [research letters]. JAMA. 2005; 283: 12901291.